{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T13:13:33Z","timestamp":1790860413905,"version":"4.1.0"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/j.saa.2022.121523","type":"journal-article","created":{"date-parts":[[2022,6,18]],"date-time":"2022-06-18T11:34:12Z","timestamp":1655552052000},"page":"121523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"special_numbering":"C","title":["Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic \u2013 Spectralprint recognition study"],"prefix":"10.1016","volume":"280","author":[{"given":"Sara","family":"El-Hanboushy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hoda M.","family":"Marzouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin M.","family":"Fayez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abdelkawy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayam M.","family":"Lotfy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.saa.2022.121523_b0005","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1016\/j.amepre.2017.05.014","article-title":"Medical expenditures associated with hypertension in the US, 2000\u20132013","volume":"53","author":"Zhang","year":"2017","journal-title":"Am. J. Prev. Med."},{"key":"10.1016\/j.saa.2022.121523_b0010","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"The Lancet"},{"key":"10.1016\/j.saa.2022.121523_b0015","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1093\/eurheartj\/ehaa433","article-title":"Association of hypertension and antihypertensive treatment with COVID-19 mortality: a retrospective observational study","volume":"41","author":"Gao","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.saa.2022.121523_b0020","unstructured":"H.M.s.S.O. British Pharmacopoeia Commission, British Pharmacopoeia, London, United Kingdom, 2013."},{"key":"10.1016\/j.saa.2022.121523_b0025","unstructured":"S.C. Sweetman, Martindale: the complete drug reference, Pharmaceutical press London, Place, Published, 2009."},{"issue":"6","key":"10.1016\/j.saa.2022.121523_b0030","first-page":"415","article-title":"Antihypertensive drugs in COVID-19 infection, European Heart Journal-Cardiovascular","volume":"6","author":"Pinto-Sietsma","year":"2020","journal-title":"Pharmacotherapy"},{"issue":"1","key":"10.1016\/j.saa.2022.121523_b0035","doi-asserted-by":"crossref","DOI":"10.1038\/s41421-020-00221-6","article-title":"Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients","volume":"6","author":"Yan","year":"2020","journal-title":"Cell Discovery"},{"key":"10.1016\/j.saa.2022.121523_b0040","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"10.1016\/j.saa.2022.121523_b0045","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1093\/eurheartj\/ehaa487","article-title":"Renin\u2013angiotensin system inhibitors in the COVID-19 pandemic: consequences of antihypertensive drugs","volume":"41","author":"Ruilope","year":"2020","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.saa.2022.121523_b0050","first-page":"149","article-title":"Conflicts over calcium and the treatment of COVID-19, Evolution, Medicine, and Public","volume":"9","author":"Crespi","year":"2021","journal-title":"Health"},{"issue":"5","key":"10.1016\/j.saa.2022.121523_b0055","doi-asserted-by":"crossref","DOI":"10.1016\/j.dsx.2021.102210","article-title":"Association of calcium channel blocker use with clinical outcome of COVID-19: A meta-analysis","volume":"15","author":"Alsagaff","year":"2021","journal-title":"Diabetes Metabolic Syndrome: Clin. Res. Rev."},{"issue":"2","key":"10.1016\/j.saa.2022.121523_b0060","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41440-021-00786-z","article-title":"Clinical outcomes of hypertensive patients with COVID-19 receiving calcium channel blockers: a systematic review and meta-analysis","volume":"45","author":"Kow","year":"2022","journal-title":"Hypertens. Res."},{"key":"10.1016\/j.saa.2022.121523_b0065","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.saa.2014.12.096","article-title":"Novel spectrophotometric methods for simultaneous determination of amlodipine, valsartan and hydrochlorothiazide in their ternary mixture","volume":"140","author":"Lotfy","year":"2015","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0070","first-page":"43","article-title":"Advanced Amplitude Centering as an invigorating Manipulation for Unifird Wavelength spectral resolution of ternary mixtures","volume":"9","author":"Saleh","year":"2017","journal-title":"Int. J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.saa.2022.121523_b0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2019\/5719651","article-title":"Simultaneous determination of amlodipine, hydrochlorothiazide, and valsartan in pharmaceutical products by a combination of full spectrum measurement and kalman filter algorithm","volume":"2019","author":"Quynh Trang","year":"2019","journal-title":"Adv. Mater. Sci. Eng."},{"key":"10.1016\/j.saa.2022.121523_b0080","doi-asserted-by":"crossref","first-page":"692","DOI":"10.5740\/jaoacint.16-0195","article-title":"Novel pure component contribution algorithm (PCCA) and UHPLC methods for separation and quantification of amlodipine, valsartan, and hydrochlorothiazide in ternary mixture","volume":"100","author":"Mowaka","year":"2017","journal-title":"J. AOAC Int."},{"issue":"1","key":"10.1016\/j.saa.2022.121523_b0085","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/chromsci\/bms200","article-title":"Concurrent estimation of amlodipine besylate, hydrochlorothiazide and valsartan by RP-HPLC, HPTLC and UV\u2013spectrophotometry","volume":"52","author":"Sharma","year":"2014","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2022.121523_b0090","first-page":"1","article-title":"A validated UV spectrophotometric method for the simultaneous estimation of amlodipine besylate, valsartan and hydrochlorothiazide in bulk and in combined tablet dosage form","volume":"5","author":"Jothieswari","year":"2010","journal-title":"J. Pharmaceut. Biomed. Sci."},{"key":"10.1016\/j.saa.2022.121523_b0095","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2013\/273102","article-title":"Sequential spectrophotometric method for the simultaneous determination of amlodipine, valsartan, and hydrochlorothiazide in coformulated tablets","volume":"2013","author":"Darwish","year":"2013","journal-title":"Int. J. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0100","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijleo.2020.165110","article-title":"Development of a chemometric-assisted spectrophotometric method for quantitative simultaneous determination of Amlodipine and Valsartan in commercial tablet","volume":"218","author":"Darbandi","year":"2020","journal-title":"Optik"},{"key":"10.1016\/j.saa.2022.121523_b0105","doi-asserted-by":"crossref","DOI":"10.1016\/j.jchromb.2020.122295","article-title":"High performance liquid chromatographic assay of amlodipine, valsartan and hydrochlorothiazide simultaneously and its application to pharmaceuticals, urine and plasma analysis","volume":"1155","author":"Shaikh","year":"2020","journal-title":"J. Chromatogr. B"},{"issue":"5","key":"10.1016\/j.saa.2022.121523_b0110","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.jpha.2017.06.001","article-title":"Application of an LC\u2013MS\/MS method for the analysis of amlodipine, valsartan and hydrochlorothiazide in polypill for a bioequivalence study","volume":"7","author":"Shah","year":"2017","journal-title":"J. Pharm. Anal."},{"key":"10.1016\/j.saa.2022.121523_b0115","doi-asserted-by":"crossref","first-page":"S1381","DOI":"10.1016\/j.arabjc.2013.04.012","article-title":"Validated stability-indicating HPLC-DAD method of analysis for the antihypertensive triple mixture of amlodipine besylate, valsartan and hydrochlorothiazide in their tablets","volume":"10","author":"Shaalan","year":"2017","journal-title":"Arabian J. Chem."},{"key":"10.1016\/j.saa.2022.121523_b0120","first-page":"00188","article-title":"Development and validation of stability indicating HPLC method for the simultaneous analysis of amlodipine, hydrochlorothiazide and valsartan in pharmaceutical formulation","volume":"6","author":"Osman","year":"2017","journal-title":"J. Anal. Pharm. Res."},{"key":"10.1016\/j.saa.2022.121523_b0125","unstructured":"USP, United States Pharmacopeia and National Formulary (USP 38-NF 33), 2015."},{"key":"10.1016\/j.saa.2022.121523_b0130","first-page":"368","article-title":"Simultaneous determination of valsartan, amlodipine besylate and hydrochlorothiazide using capillary zone electrophoresis (CZE)","volume":"70","author":"Ebeid","year":"2015","journal-title":"Die Pharmazie-Int. J. Pharmaceut. Sci."},{"key":"10.1016\/j.saa.2022.121523_b0135","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jpba.2015.01.059","article-title":"A new, rapid, stability-indicating UPLC method for separation and determination of impurities in amlodipine besylate, valsartan and hydrochlorothiazide in their combined tablet dosage form","volume":"109","author":"Vojta","year":"2015","journal-title":"J. Pharm. Biomed. Anal."},{"issue":"3","key":"10.1016\/j.saa.2022.121523_b0140","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1556\/AChrom.27.2015.3.4","article-title":"Development of a new UPLC method for simultaneous determination of valsartan, amlodipine besylate, and hydrochlorothiazide pharmaceutical products","volume":"27","author":"Lahsini","year":"2015","journal-title":"Acta Chromatogr."},{"key":"10.1016\/j.saa.2022.121523_b0145","first-page":"188","article-title":"Development and validation of stability indicating HPLC method for the simultaneous analysis of amlodipine, hydrochlorothiazide and valsartan in pharmaceutical formulation","volume":"6","author":"Osman","year":"2017","journal-title":"Pharm Methods"},{"issue":"1","key":"10.1016\/j.saa.2022.121523_b0150","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ijcas.2013.03.003","article-title":"Simultaneous estimation of hydrochlorothiazide, amlodipine, and losartan in tablet dosage form by RP-HPLC","volume":"4","author":"Tengli","year":"2013","journal-title":"Int. J. Chem. Anal. Sci."},{"issue":"2","key":"10.1016\/j.saa.2022.121523_b0155","first-page":"215","article-title":"Gradient HPLC-DAD Determination of the Antihypertensive Mixture of Amlodipine Besylate, Valsartan, and Hydrochlorothiazide in Combined Pharmaceutical Tablets","volume":"35","author":"Shaalan","year":"2012","journal-title":"J. :Liquid Chromatogr. Related Technologies"},{"issue":"06","key":"10.1016\/j.saa.2022.121523_b0160","doi-asserted-by":"crossref","first-page":"422","DOI":"10.4236\/ajac.2012.36055","article-title":"Development and validation of HPLC method for simultaneous determination of amlodipine, valsartan, hydrochlorothiazide in dosage form and spiked human plasma","volume":"03","author":"El-Gizawy","year":"2012","journal-title":"Am. J. Anal. Chem."},{"key":"10.1016\/j.saa.2022.121523_b0165","first-page":"82","article-title":"Utilization of 1, 2-Naphthoquine-4-Sulfonate (NQS) for Development and Validation of Stability indicating HPLC method for the Simultaneous Analysis of Amlodipine, Hydrochlorothiazide and Valsartan in Pharmaceutical Formulation","volume":"5","author":"Mohammed Osman","year":"2019","journal-title":"Int. J. Bioanal. Methods Bioequival. Stud."},{"issue":"13","key":"10.1016\/j.saa.2022.121523_b0170","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1039\/D0AY00022A","article-title":"The synthesis and characterization of 3D mesoporous CeO 2 hollow spheres as a modifier for the simultaneous determination of amlodipine, hydrochlorothiazide and valsartan","volume":"12","author":"Farvardin","year":"2020","journal-title":"Anal. Methods"},{"issue":"3","key":"10.1016\/j.saa.2022.121523_b0175","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1039\/C4AY02511C","article-title":"Electrochemical evaluation of a boron-doped diamond electrode for simultaneous determination of an antihypertensive ternary mixture of amlodipine, hydrochlorothiazide and valsartan in pharmaceuticals","volume":"7","author":"Mansano","year":"2015","journal-title":"Anal. Methods"},{"key":"10.1016\/j.saa.2022.121523_b0180","first-page":"1","article-title":"Ultraviolet spectrophotometric methods for the determination of the minor component presented in fixed-dose pharmaceutical combinations through the last two decades (2000\u20132020), Future","volume":"7","author":"Obaydo","year":"2021","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.saa.2022.121523_b0185","first-page":"40","article-title":"Recent development in ultraviolet spectrophotometry through the last decade (2006\u20132016): A review, International","volume":"8","author":"Lotfy","year":"2016","journal-title":"J. Pharm. Pharmaceut. Sci."},{"key":"10.1016\/j.saa.2022.121523_b0190","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2022.121036","article-title":"The Power of High Impact Amplitude Manipulation (HIAM) technique for Extracting the Basic Spectra of Two Fixed-dose Combinations (FDC)-Spectrophotometric Purity Analysis via Spectral Contrast Angle","volume":"273","author":"Saleh","year":"2022","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0195","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.119080","article-title":"Trade-off efficacy and data processing strategy in the power of spectral resolution of co-formulated antihypertensive pharmaceuticals","volume":"247","author":"Rostom","year":"2021","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"issue":"1","key":"10.1016\/j.saa.2022.121523_b0200","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pharma.2020.07.007","article-title":"Evaluation of assay and in-vitro dissolution profile of certain fixed-dose combination using green analytical method Ann","volume":"79","author":"Lotfy","year":"2021","journal-title":"Pharm. Fr."},{"key":"10.1016\/j.saa.2022.121523_b0205","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.saa.2012.04.095","article-title":"Comparative study of novel spectrophotometric methods manipulating ratio spectra: an application on pharmaceutical ternary mixture of omeprazole, tinidazole and clarithromycin","volume":"96","author":"Lotfy","year":"2012","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0210","doi-asserted-by":"crossref","first-page":"121063","DOI":"10.1016\/j.saa.2022.121063","article-title":"Fingerprinting and iso-absorptive resolution techniques for the spectrally overlapping Dutasteride and Silodosin mixture: Content uniformity testing along with greenness profile assessment","volume":"273","author":"Rostom","year":"2022","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0215","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.saa.2018.04.004","article-title":"Novel absorptivity centering method utilizing normalized and factorized spectra for analysis of mixtures with overlapping spectra in different matrices using built-in spectrophotometer software","volume":"200","author":"Lotfy","year":"2018","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0220","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2019.117998","article-title":"Novel feature extraction approach for achieving potential spectral resolution: Green analytical application on zofenopril calcium and hydrochlorothiazide in their spectrally overlapping binary mixture","volume":"230","author":"Lotfy","year":"2020","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0225","first-page":"735","article-title":"Absorbance subtraction and amplitude modulation as novel spectrophotometric methods for the analysis of binary mixtures","volume":"6","author":"Lotfy","year":"2014","journal-title":"Int. J. Pharm. Pharm. Sci"},{"key":"10.1016\/j.saa.2022.121523_b0230","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2020.118551","article-title":"The concept of Relative Absorptivity Distribution for enhancing disbanding power of spectrophotometric technique to resolve co-formulated tablets: A tool for purity index and uniformity assessment","volume":"239","author":"Lotfy","year":"2020","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0235","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2021.119943","article-title":"Evaluation of in silico and in lab sample enrichment techniques for the assessment of challengeable quaternary combination in critical ratio","volume":"260","author":"Ahmed","year":"2021","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0240","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.saa.2014.02.044","article-title":"Development and validation of simultaneous spectrophotometric and TLC-spectrodensitometric methods for determination of beclomethasone dipropionate and salbutamol in combined dosage form","volume":"128","author":"Samir","year":"2014","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.saa.2022.121523_b0245","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2019.117339","article-title":"Advanced approaches for the treatment and amplification of weak spectral signals produced by critical concentrations in white multicomponent systems","volume":"224","author":"Lotfy","year":"2020","journal-title":"Spectrochim. Acta Part A Mol. Biomol. Spectrosc."},{"issue":"6","key":"10.1016\/j.saa.2022.121523_b0250","first-page":"718","article-title":"Application of successive and progressive spectrophotometric resolution for the analysis of partially or completely overlapping ternary mixtures, Analytical","volume":"6","author":"Lotfy","year":"2016","journal-title":"Chem. Lett."},{"key":"10.1016\/j.saa.2022.121523_b0255","unstructured":"USP, United States Pharmacopeia and National Formulary (USP 42-NF 37), 2019."},{"key":"10.1016\/j.saa.2022.121523_b0260","unstructured":"ICH, International Conference on Harmonization (ICH),Q2B: Validation of Analytical Procedures : Methodology, 62, US FDA Federal Register, 1997."},{"key":"10.1016\/j.saa.2022.121523_b0265","unstructured":"T. Coyle, The characterization of chemical purity. Organic compounds: Ed. by LAK Staveley, Butterworths, London, 1971, Supplement to \u201cPure and Applied Chemistry\u201d Elsevier 1972."},{"issue":"6","key":"10.1016\/j.saa.2022.121523_b0270","doi-asserted-by":"crossref","first-page":"2695","DOI":"10.1021\/cr068359e","article-title":"Green analytical methodologies","volume":"107","author":"Keith","year":"2007","journal-title":"Chem. Rev."},{"issue":"15","key":"10.1016\/j.saa.2022.121523_b0275","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1039\/C6AY00478D","article-title":"Metrics for green analytical chemistry","volume":"8","author":"Tobiszewski","year":"2016","journal-title":"Anal. Methods"},{"key":"10.1016\/j.saa.2022.121523_b0280","unstructured":"(Emergency Planning and Community Right-to-Know Act; Section 313 Toxic Release Inventory (TRI) Chemical List for Reporting Year 2019. (https:\/\/www.epa.gov\/sites\/production\/files\/2020-02\/documents\/ry_2019_tri_chemical_list_0.pdf))."},{"key":"10.1016\/j.saa.2022.121523_b0285","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.trac.2012.03.013","article-title":"Analytical Eco-Scale for assessing the greenness of analytical procedures","volume":"37","author":"Ga\u0142uszka","year":"2012","journal-title":"TrAC, Trends Anal. Chem."},{"key":"10.1016\/j.saa.2022.121523_b0290","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.talanta.2018.01.013","article-title":"A new tool for the evaluation of the analytical procedure: Green Analytical Procedure Index","volume":"181","author":"P\u0142otka-Wasylka","year":"2018","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2022.121523_b0295","doi-asserted-by":"crossref","first-page":"10076","DOI":"10.1021\/acs.analchem.0c01887","article-title":"AGREE\u2014Analytical GREEnness metric approach and software","volume":"92","author":"Pena-Pereira","year":"2020","journal-title":"Anal. Chem."}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142522006722?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142522006722?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T02:05:14Z","timestamp":1761357914000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142522006722"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11]]},"references-count":59,"alternative-id":["S1386142522006722"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2022.121523","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Eco-friendly spectrophotometric evaluation of triple-combination therapies in the treatment strategy of patients suffering from hypertension during coronavirus pandemic \u2013 Spectralprint recognition study","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2022.121523","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"121523"}}